# Ethics Committee Submission Template

**Institution:** Shridevi Institute of Medical Sciences & Research Hospital (SIMS&RH)

**Ethics Committee:** Institutional Ethics Committee (IEC)

**Date of Submission:** __________

---

## 1. Title of the Study
Epidemiological Study on Prevalence, Distribution, Phenotypes, Determinants, Temporal and Spatial Associations of Allergy with Emphasis on Microbiome, Microplastics, Quality of Life, Treatment Perception, and Comorbidities in SIMS&RH Tumkur, Karnataka

## 2. Principal Investigator Details
- Name: __________
- Designation: __________
- Department: __________
- Contact: Phone: __________ Email: __________
- Qualifications: __________

## 3. Co-Investigator Details
[List all co-investigators with their names, designations, departments, and contact details]

## 4. Study Site(s)
- Primary: SIMS&RH, Tumkur, Karnataka
- Secondary: Selected community areas in Tumkur district

## 5. Study Duration
- Proposed start date: __________
- Proposed end date: __________
- Total duration: 16 months

## 6. Background and Rationale
[Include detailed background as per main protocol]

## 7. Objectives
[Include all objectives as per main protocol]

## 8. Study Design
- Type: Cross-sectional epidemiological study with nested case-control components
- Study population: Residents of Tumkur district aged 5-65 years
- Sample size: 1,200 participants
- Sampling method: Multi-stage stratified random sampling

## 9. Methodology
[Brief summary of data collection methods, including questionnaire administration, clinical examination, skin prick testing, and laboratory investigations]

## 10. Potential Risks and Benefits

### Potential Risks:
- **Minimal physical risks:** Skin prick testing may cause mild discomfort, itching, or rarely allergic reactions
- **Psychological risks:** Anxiety related to testing or diagnosis
- **Privacy risks:** Potential breach of confidentiality
- **Social risks:** Stigma associated with allergy diagnosis

### Potential Benefits:
- **Individual benefits:** Early diagnosis and appropriate management of allergic conditions
- **Community benefits:** Better understanding of local allergy patterns and risk factors
- **Scientific benefits:** Contribution to allergy epidemiology in Indian context

### Risk Mitigation:
- Trained medical personnel will conduct all procedures
- Emergency medications and equipment available
- Strict confidentiality measures
- Voluntary participation with right to withdraw

## 11. Informed Consent Process

### Consent for Adults:
- Written informed consent in local language (Kannada) and English
- Consent form includes study details, procedures, risks, benefits, and rights
- Separate consent for biological sample collection and storage

### Consent for Children (5-17 years):
- Parental/guardian written consent
- Child assent for children 7-17 years
- Simplified consent forms for minors

### Consent for Illiterate Participants:
- Thumb impression with impartial witness
- Verbal consent read aloud and explained

### Consent Process:
- Conducted in private setting
- Sufficient time for questions
- No coercion or undue influence
- Right to withdraw at any time

## 12. Confidentiality and Data Protection

### Data Management:
- Anonymous data collection where possible
- Unique participant identification numbers
- Password-protected electronic databases
- Secure storage of physical records

### Biological Samples:
- Coded samples without personal identifiers
- Secure storage in -80Â°C freezers
- Limited access to authorized personnel only
- Destruction protocol after analysis

### Data Sharing:
- Aggregate data only for publications
- Individual data not shared without consent
- Compliance with data protection regulations

## 13. Vulnerable Populations
- Children (5-17 years): Additional protections as per national guidelines
- Pregnant women: Excluded from certain procedures
- Illiterate individuals: Special consent procedures
- Economically disadvantaged: No financial incentives that could influence participation

## 14. Compensation for Injury
- Free medical treatment for any study-related injury
- Transportation and medical expenses covered
- No upper limit on compensation
- Independent assessment for compensation claims

## 15. Publication Policy
- Authorship based on ICMJE criteria
- Acknowledgment of IEC approval in all publications
- Sharing of results with participants and community

## 16. Monitoring and Auditing
- Regular progress reports to IEC
- Data safety monitoring
- Protocol deviations reported immediately
- Annual continuing review

## 17. Budget
[Attach detailed budget showing funding sources and utilization]

## 18. Regulatory Approvals
- IEC approval required before study initiation
- Scientific and ethical review from relevant authorities
- Registration with Clinical Trials Registry of India (CTRI) if applicable

## 19. Conflict of Interest
- None declared
- Funding source: __________
- No industry sponsorship

## 20. References
[List relevant references]

## Annexures
1. Main study protocol
2. Participant information sheet
3. Informed consent forms (adult, minor, illiterate)
4. Case report forms
5. Investigator CVs
6. Budget details
7. GCP training certificates
8. Laboratory certifications
9. Insurance documents

---

**Principal Investigator Signature:** __________

**Date:** __________

**IEC Review Date:** __________

**IEC Decision:** __________

**IEC Comments:** __________
